Okta vs Biogen
Which is stronger right now? The dated snapshot below answers it with quality, valuation ceiling, risk, and timing — side by side, then the full decision brief.
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Key facts — quick answer
- OKTA = Okta (US) · BIIB = Biogen (US).
- Snapshot 2026-08-29: OKTA $134.42 · signal LONG · ret +57.1% ‖ BIIB $221.50 · signal LONG · ret +51.9%.
- The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.
Snapshot comparison (2026-08-29)
| OKTA | BIIB | |
|---|---|---|
| Company | Okta | Biogen |
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Technology | Healthcare |
| Price | $134.42 | $221.50 |
| Signal | LONG · +66.2% | LONG · +59.8% |
| Total return | +57.1% | +51.9% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
See the full decision brief
Deeper comparison — Okta (OKTA) vs Biogen (BIIB)
Beyond the snapshot above, the real comparison comes from running the same workflow on both companies: score quality, set the valuation ceiling, and write the break conditions for each. The framework stays identical; only the data changes.
| Dimension | OKTA | BIIB |
|---|---|---|
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Technology | Healthcare |
| STM signal | LONG | LONG |
| uPnL | +66.2% | +59.8% |
| Total return | +57.1% | +51.9% |
Use this table as a starting point, not an answer. The decision comes from running the full workflow on both companies — OKTA brief · BIIB brief — and comparing the outputs side by side.
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google.
Cite this page
Balance Labs Research Desk. "Okta vs Biogen" https://balancelabs.app/stocks/compare/okta-vs-biib. Data snapshot: . CC BY 4.0 with attribution.
Ask anything about OKTA
Same AI engine as this decision brief — grounded in live tool reports.
30 free credits monthly · no card required · research support, not advice
← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.